Orally-active ice inhibitors for the treatment of inflammatory and autoimmune diseases.

被引：0
|
作者：
Randle, JCR [1 ]
机构：
[1] Vertex Pharmaceut Inc, Cambridge, MA 02319 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
200-MEDI
引用
收藏
页码：U944 / U944
页数：1
相关论文
共 50 条
  • [1] Novel orally active NF-κB inhibitors for the treatment of inflammatory diseases
    Leban, Johann
    Wuzik, Andreas
    Gotschlich, Astrid
    Lemstra, Sylvia
    Kissel, Maria
    Doblhofer, Robert
    Strobl, Stefan
    Hamm, Svetlana
    CYTOKINE, 2007, 39 (01) : 22 - 23
  • [2] NEW ORALLY-ACTIVE SERINE-PROTEASE INHIBITORS
    SENOKUCHI, K
    NAKAI, H
    NAKAYAMA, Y
    ODAGAKI, Y
    SAKAKI, K
    KATO, M
    MARUYAMA, T
    MIYAZAKI, T
    ITO, H
    KAMIYASU, K
    KIM, S
    KAWAMURA, M
    HAMANAKA, N
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) : 2521 - 2523
  • [3] Design of map kinases inhibitors for the treatment of inflammatory diseases.
    Salituro, FG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U437 - U437
  • [4] JAK inhibitors for the treatment of autoimmune and inflammatory diseases
    Jamilloux, Yvan
    El Jammal, Thomas
    Vuitton, Lucine
    Gerfaud-Valentin, Mathieu
    Kerever, Sebastien
    Seve, Pascal
    AUTOIMMUNITY REVIEWS, 2019, 18 (11)
  • [5] NEW ORALLY-ACTIVE LEUKOCYTE RECRUITMENT INHIBITORS AS ANTIINFLAMMATORY AGENTS
    PERUMATTAM, J
    HAMILTON, G
    WU, JP
    CONFER, WL
    SHAO, C
    HATOUM, HN
    VENKATARAMAN, B
    BLOK, N
    YANG, XJ
    LOWE, VC
    LAEMONT, K
    ENDEMANN, G
    BRYANT, CM
    FENG, Y
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 121 - MEDI
  • [6] Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases
    Patterson, H.
    Nibbs, R.
    McInnes, I.
    Siebert, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 176 (01): : 1 - 10
  • [7] DESIGN OF ORALLY-ACTIVE, NONPEPTIDIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE
    BROWN, FJ
    ANDISIK, DW
    BERNSTEIN, PR
    BRYANT, CB
    CECCARELLI, C
    DAMEWOOD, JR
    WOOLSON, SA
    EDWARDS, PD
    EARLEY, RA
    FEENEY, S
    GREEN, RC
    GOMES, B
    KOSMIDER, BJ
    KRELL, RD
    SHAW, A
    STEELMAN, GB
    THOMAS, RN
    VACEK, EP
    VEALE, CA
    TUTHILL, PA
    WARNER, P
    WILLIAMS, JC
    WOLANIN, DJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (09) : 1259 - 1261
  • [8] ORALLY-ACTIVE, INTRACELLULAR INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE (HLE)
    FINKE, PE
    DORN, CP
    KISSINGER, AL
    SHAH, SK
    BALL, RG
    CHABIN, R
    DAVIE, P
    DELLEA, PS
    DOHERTY, JB
    DURETTE, PL
    FLETCHER, DS
    GRIFFIN, PR
    GREEN, BG
    HALE, JJ
    HANLON, WA
    HAND, KM
    HUMES, JL
    KIECZYKOWSKI, GR
    KLATT, TD
    LANZA, TJ
    KNIGHT, WB
    MACCOSS, M
    MILLER, DS
    MUMFORD, RA
    PACHOLOK, SG
    PETERSON, LP
    POE, M
    UNDERWOOD, DJ
    WILLIAMS, DT
    WILLIAMS, HR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 83 - MEDI
  • [9] SUBSTITUTED CHROMENES AS POTENT, ORALLY-ACTIVE 5-LIPOXYGENASE INHIBITORS
    SATOH, Y
    STANTON, JL
    HUTCHISON, AJ
    LIBBY, AH
    KOWALSKI, TJ
    LEE, WH
    WHITE, DH
    KIMBLE, EF
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (23) : 3580 - 3594
  • [10] Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases
    Zhang, Datong
    Gong, He
    Meng, Fancui
    MOLECULES, 2021, 26 (16):
12345